Stemulite Manufacturer, Metabolic Research, Inc., Announces the Expansion of Its Science Advisory Board
Dr. Marvell Scott, MD, CSCS, has been appointed to the Company’s Science Advisory Board. Dr. Scott is a New York State licensed, nationally board certified medical doctor whose emphasis is preventative care and sports medicine. He is also a nationally accredited exercise and performance expert who designs specialized fitness and wellness programs.
Dr. Scott has had a lifelong interest in sports and physiology including winning a state bodybuilding championship as a teen and followed by competing in the Big Ten at the University of Illinois as a running back. He later played two seasons as a professional indoor football player in addition to playing semi-pro baseball as a pitcher.
Robert Bakker, Metabolic CEO, stated, “Dr. Scott’s unique combination of sports experience and medical expertise adds important new dimensions to the Science Advisory Board. This appointment furthers our program to position our Stemulite(TM) brand of nutritional supplements as a healthy alternative to steroids.”
Dr. Scott joins Science Advisory Board head Dr. Rob Shorr, and Tia Owen, MTBR Chief Operating Officer, who is the Board of Directors representative on the Science Advisory Board. Dr. Shorr is also president of Cornerstone Pharmaceuticals, Inc.
For more information about Metabolic Research, Inc., see www.metabolicresearchinc.com. For more information about Metabolic’s products, see www.stemulite.com or www.mystemulite.com.
This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms “believes,” “belief,” “expects,” “intends,” “anticipates,” “will,” or “plans” to be uncertain and forward looking. The forward-looking statements contained herein are also subject generally to other risks and uncertainties that are described from time to time in the company’s reports and registration statements filed with the Securities and Exchange Commission.
Similar Posts:
Popularity: 5% [?]
If you enjoyed this post, make sure you subscribe to my RSS feed!
